Search Results - "Hwa, Yi Lisa"

Risk stratification of smoldering multiple myeloma incorporating revised IMWG diagnostic criteria by Lakshman, Arjun, Rajkumar, S. Vincent, Buadi, Francis K., Binder, Moritz, Gertz, Morie A., Lacy, Martha Q., Dispenzieri, Angela, Dingli, David, Fonder, Amie L., Hayman, Suzanne R., Hobbs, Miriam A., Gonsalves, Wilson I., Hwa, Yi Lisa, Kapoor, Prashant, Leung, Nelson, Go, Ronald S., Lin, Yi, Kourelis, Taxiarchis V., Warsame, Rahma, Lust, John A., Russell, Stephen J., Zeldenrust, Steven R., Kyle, Robert A., Kumar, Shaji K.

“…In 2014, the International Myeloma Working Group reclassified patients with smoldering multiple myeloma (SMM) and bone marrow-plasma cell percentage (BMPC%) ≥…”
Get full text

Bone marrow plasma cells 20% or greater discriminate presentation, response, and survival in AL amyloidosis by Muchtar, Eli, Gertz, Morie A., Kourelis, Taxiarchis V., Sidana, Surbhi, Go, Ronald S., Lacy, Martha Q., Buadi, Francis K., Dingli, David, Hayman, Suzanne R., Kapoor, Prashant, Leung, Nelson, Fonder, Amie, Hobbs, Miriam, Lisa Hwa, Yi, Gonsalves, Wilson, Warsame, Rahma, Russell, Stephen, Lust, John A., Lin, Yi, Zeldenrust, Steven, Rajkumar, S. Vincent, Kyle, Robert A., Kumar, Shaji K., Dispenzieri, Angela

“…We explored the association between bone marrow plasma cells (BMPCs) and disease presentation and outcome among 1574 AL patients. Three BMPC groups were…”
Get full text

Characterization and prognostic implication of delayed complete response in AL amyloidosis by Muchtar, Eli, Gertz, Morie A., Kumar, Shaji K., Lacy, Martha Q., Leung, Nelson, Buadi, Francis K., Dingli, David, Hayman, Suzanne R., Go, Ronald S., Kapoor, Prashant, Gonsalves, Wilson, Kourelis, Taxiarchis V., Warsame, Rahma, Lisa Hwa, Yi, Fonder, Amie, Hobbs, Miriam, Russell, Stephen, Lust, John A., Siddiqui, Mustaqueem, Vincent Rajkumar, S., Kyle, Robert A., Dispenzieri, Angela

“…Introduction Little is known on continued response following completion of therapy in light chain (AL) amyloidosis. Methods We studied 373 AL amyloidosis…”
Get full text

Transition of LINE-1 DNA methylation status and altered expression in first and third trimester placentas by He, Zhi-ming, Li, Jinping, Hwa, Yi Lisa, Brost, Brian, Fang, Qun, Jiang, Shi-Wen

“…DNA methylation plays a critical role in the regulation of gene expression, genomic DNA stability, cell proliferation, and malignant transformation. Common…”
Get full text

Improved outcomes for newly diagnosed AL amyloidosis between 2000 and 2014: cracking the glass ceiling of early death by Muchtar, Eli, Gertz, Morie A., Kumar, Shaji K., Lacy, Martha Q., Dingli, David, Buadi, Francis K., Grogan, Martha, Hayman, Suzanne R., Kapoor, Prashant, Leung, Nelson, Fonder, Amie, Hobbs, Miriam, Hwa, Yi Lisa, Gonsalves, Wilson, Warsame, Rahma, Kourelis, Taxiarchis V., Russell, Stephen, Lust, John A., Lin, Yi, Go, Ronald S., Zeldenrust, Steven, Kyle, Robert A., Rajkumar, S.Vincent, Dispenzieri, Angela

“…In light of major advances in immunoglobulin light chain (AL) amyloidosis, we evaluated the trends in presentation, management, and outcome among 1551 newly…”
Get full text

Depth of organ response in AL amyloidosis is associated with improved survival: grading the organ response criteria by Muchtar, Eli, Dispenzieri, Angela, Leung, Nelson, Lacy, Martha Q., Buadi, Francis K., Dingli, David, Grogan, Martha, Hayman, Suzanne R., Kapoor, Prashant, Hwa, Yi Lisa, Fonder, Amie, Hobbs, Miriam, Chakraborty, Rajshekhar, Gonsalves, Wilson, Kourelis, Taxiarchis V., Warsame, Rahma, Russell, Stephen, Lust, John A., Lin, Yi, Go, Ronald S., Zeldenrust, Steven, Kyle, Robert A., Rajkumar, S. Vincent, Kumar, Shaji K., Gertz, Morie A.

“…Organ recovery following anti-plasma cell therapy is associated with improved outcome in patients with AL amyloidosis. Current organ response criteria do not…”
Get full text

Ten‐year survivors in AL amyloidosis: characteristics and treatment pattern by Muchtar, Eli, Gertz, Morie A., Lacy, Martha Q., Go, Ronald S., Buadi, Francis K., Dingli, David, Grogan, Martha, AbouEzzeddine, Omar F., Hayman, Suzanne R., Kapoor, Prashant, Leung, Nelson, Fonder, Amie, Hobbs, Miriam, Hwa, Yi Lisa, Gonsalves, Wilson, Warsame, Rahma, Kourelis, Taxiarchis V., Russell, Stephen, Lust, John A., Lin, Yi, Zeldenrust, Steven, Kyle, Robert A., Rajkumar, S. Vincent, Kumar, Shaji K., Dispenzieri, Angela

“…Summary Improvement in survival in Light chain (AL) amyloidosis has been seen over recent decades, enabling more patients to achieve long‐term survival…”
Get full text

Optimizing deep response assessment for AL amyloidosis using involved free light chain level at end of therapy: failure of the serum free light chain ratio by Muchtar, Eli, Dispenzieri, Angela, Leung, Nelson, Lacy, Martha Q., Buadi, Francis K., Dingli, David, Hayman, Suzanne R., Kapoor, Prashant, Hwa, Yi Lisa, Fonder, Amie, Hobbs, Miriam, Gonsalves, Wilson, Kourelis, Taxiarchis V., Warsame, Rahma, Russell, Stephen J., Lust, John A., Lin, Yi, Go, Ronald S., Zeldenrust, Steven R., Kyle, Robert A., Rajkumar, S. Vincent, Kumar, Shaji K., Gertz, Morie A.

Get full text

Enhancing the R‐ISS classification of newly diagnosed multiple myeloma by quantifying circulating clonal plasma cells by Gonsalves, Wilson I., Jevremovic, Dragan, Nandakumar, Bharat, Dispenzieri, Angela, Buadi, Francis K., Dingli, David, Lacy, Martha Q., Hayman, Suzanne R., Kapoor, Prashant, Leung, Nelson, Fonder, Amie, Hobbs, Miriam, Hwa, Yi Lisa, Muchtar, Eli, Warsame, Rahma, Kourelis, Taxiarchis V., Russell, Stephen, Lust, John A., Lin, Yi, Go, Ronald S., Siddiqui, Mustaqeem A., Kyle, Robert A., Gertz, Morie A., Rajkumar, S. Vincent, Kumar, Shaji K.

“…Our prior studies identified the prognostic significance of quantifying cPCs by multiparametric flow cytometry (MFC) in newly diagnosed multiple myeloma (NDMM)…”
Get full text

Sarcopenia identified by computed tomography imaging using a deep learning–based segmentation approach impacts survival in patients with newly diagnosed multiple myeloma by Nandakumar, Bharat, Baffour, Francis, Abdallah, Nadine H., Kumar, Shaji K., Dispenzieri, Angela, Buadi, Francis K., Dingli, David, Lacy, Martha Q., Hayman, Suzanne R., Kapoor, Prashant, Leung, Nelson, Fonder, Amie, Hobbs, Miriam, Hwa, Yi Lisa, Muchtar, Eli, Warsame, Rahma, Kourelis, Taxiarchis V., Go, Ronald S., Kyle, Robert A., Gertz, Morie A., Rajkumar, S. Vincent, Klug, Jason, Korfiatis, Panagiotis, Gonsalves, Wilson I.

“…Background Sarcopenia increases with age and is associated with poor survival outcomes in patients with cancer. By using a deep learning–based segmentation…”
Get full text

Outcomes with different administration schedules of bortezomib in bortezomib, lenalidomide and dexamethasone (VRd) as first‐line therapy in multiple myeloma by Cook, Joselle, Johnson, Isla, Higgins, Alexandra, Sidana, Surbhi, Warsame, Rahma, Gonsalves, Wilson, Gertz, Morie A., Buadi, Francis, Lacy, Martha, Kapoor, Prashant, Dispenzieri, Angela, Kourelis, Taxiarchis, Dingli, David, Fonder, Amie, Hayman, Suzanne, Hobbs, Miriam, Hwa, Yi Lisa, Kyle, Robert, Leung, Nelson, Go, Ronald, Rajkumar, Vincent S., Kumar, Shaji

“…Induction therapy for multiple myeloma with bortezomib (Velcade), lenalidomide (Revlimid), and dexamethasone (d) (VRd) was traditionally administered as…”
Get full text

Relapse after complete response in newly diagnosed multiple myeloma: implications of duration of response and patterns of relapse by Sidana, Surbhi, Tandon, Nidhi, Dispenzieri, Angela, Gertz, Morie A., Buadi, Francis K., Lacy, Martha Q., Dingli, David, Fonder, Amie L., Hayman, Suzanne R., Hobbs, Miriam A., Gonsalves, Wilson I., Warsame, Rahma M., Kourelis, Taxiarchis, Hwa, Yi Lisa, Kapoor, Prashant, Kyle, Robert A., Leung, Nelson, Go, Ronald S., Rajkumar, S. Vincent, Kumar, Shaji K.

“…Achieving a complete response (CR) is associated with improved overall survival (OS) in multiple myeloma (MM), but data on duration of CR (DurCR) are limited…”
Get full text

Refining amyloid complete hematological response: Quantitative serum free light chains superior to ratio by Muchtar, Eli, Gertz, Morie A., Lacy, Martha Q., Leung, Nelson, Buadi, Francis K., Dingli, David, Hayman, Suzanne R., Go, Ronald S., Kapoor, Prashant, Gonsalves, Wilson, Kourelis, Taxiarchis V., Warsame, Rahma, Hwa, Yi Lisa, Fonder, Amie, Hobbs, Miriam, Russell, Stephen, Lust, John A., Siddiqui, Mustaqeem, Rajkumar, S. Vincent, Kyle, Robert A., Kumar, Shaji K., Dispenzieri, Angela

“…Response assessment in light chain (AL) amyloidosis is based on serum and urine monoclonal protein studies. Newly diagnosed patients (n = 373) who achieved…”
Get full text

Utilizing multiparametric flow cytometry in the diagnosis of patients with primary plasma cell leukemia by Evans, Laura A., Jevremovic, Dragan, Nandakumar, Bharat, Dispenzieri, Angela, Buadi, Francis K., Dingli, David, Lacy, Martha Q., Hayman, Suzanne R., Kapoor, Prashant, Leung, Nelson, Fonder, Amie, Hobbs, Miriam, Hwa, Yi Lisa, Muchtar, Eli, Warsame, Rahma, Kourelis, Taxiarchis V., Go, Ronald, Russell, Stephen, Lust, John A., Lin, Yi, Siddiqui, Mustaqeem, Kyle, Robert A., Gertz, Morie A., Rajkumar, S. Vincent, Kumar, Shaji K., Gonsalves, Wilson I.

“…The diagnosis of primary plasma cell leukemia (pPCL) has been made by quantifying circulating plasma cells (cPCs) morphologically on a peripheral blood (PB)…”
Get full text

Prognostic significance of acquired 1q22 gain in multiple myeloma by Audil, Hadiyah Y., Cook, Joselle M., Greipp, Patricia T., Kapoor, Prashant, Baughn, Linda B., Dispenzieri, Angela, Gertz, Morie A., Buadi, Francis K., Lacy, Martha Q., Dingli, David, Fonder, Amie L., Hayman, Suzanne R., Hobbs, Miriam A., Muchtar, Eli, Siddiqui, Mustaqeem, Gonsalves, Wilson I., Hwa, Yi Lisa, Leung, Nelson, Lin, Yi, Kourelis, Taxiarchis V., Warsame, Rahma, Kyle, Robert A., Ketterling, Rhett P., Rajkumar, S. Vincent, Kumar, Shaji K.

“…Gain of 1q22 at diagnosis portends poorer outcomes in multiple myeloma (MM), but the prognostic significance of acquired 1q22 gain is unknown. We identified 63…”
Get full text

Prognostic significance of interphase FISH in monoclonal gammopathy of undetermined significance by Lakshman, Arjun, Paul, Shilpa, Rajkumar, S. Vincent, Ketterling, Rhett P., Greipp, Patricia T., Dispenzieri, Angela, Gertz, Morie A, Buadi, Francis K., Lacy, Martha Q., Dingli, David, Fonder, Amie L., Hayman, Suzanne R., Hobbs, Miriam A., Gonsalves, Wilson I., Hwa, Yi Lisa, Kapoor, Prashant, Leung, Nelson, Go, Ronald S., Lin, Yi, Kourelis, Taxiarchis V., Warsame, Rahma, Lust, John A., Russell, Stephen J., Zeldenrust, Steven R., Kyle, Robert A., Kumar, Shaji K.

Get full text

Hypovitaminosis D Is Prevalent in Patients With Renal AL Amyloidosis and Associated With Renal Outcome by Muchtar, Eli, Drake, Matthew T, Leung, Nelson, Dispenzieri, Angela, Lacy, Martha Q, Buadi, Francis K, Dingli, David, Hayman, Suzanne R, Kapoor, Prashant, Hwa, Yi Lisa, Fonder, Amie, Hobbs, Miriam, Gonsalves, Wilson, Kourelis, Taxiarchis V, Warsame, Rahma, Russell, Stephen, Go, Ronald S, Binder, Moritz, Kyle, Robert A, Rajkumar, S Vincent, Kumar, Shaji K, Gertz, Morie A

“…Vitamin D deficiency is common, but no data have been reported on vitamin D levels in light chain (AL) amyloidosis. In this exploratory study, stored serum…”
Get full text

Impact of prior melphalan exposure on stem cell collection in light chain amyloidosis by Sidana, Surbhi, Tandon, Nidhi, Gertz, Morie A., Dispenzieri, Angela, Buadi, Francis K., Lacy, Martha Q., Dingli, David, Fonder, Amie L., Hayman, Suzanne R., Hobbs, Miriam A., Gonsalves, Wilson I., Hwa, Yi Lisa, Kapoor, Prashant, Kyle, Robert A., Leung, Nelson, Go, Ronald S., Lust, John A., Russell, Stephen J., Zeldenrust, Steven R., Rajkumar, S. Vincent, Hogan, William J., Kumar, Shaji K.

“…Use of melphalan in multiple myeloma was observed to have a deleterious effect on stem cell collection in older studies. There is limited data on the impact of…”
Get full text

Phase 1/2 trial of ixazomib, cyclophosphamide and dexamethasone in patients with previously untreated symptomatic multiple myeloma by Kumar, Shaji K., Buadi, Francis K., LaPlant, Betsy, Halvorson, Alese, Leung, Nelson, Kapoor, Prashant, Dingli, David, Gertz, Morie A., Go, Ronald S., Bergsagel, P. Leif, Lin, Yi, Dispenzieri, Angela, Hwa, Yi Lisa, Fonder, Amie, Hobbs, Miriam, Fonseca, Rafael, Hayman, Suzanne R., Stewart, A. Keith, Lust, John A., Mikhael, Joseph, Gonsalves, Wilson, Reeder, Craig, Skacel, Tomas, Rajkumar, S. Vincent, Lacy, Martha Q.

“…Ixazomib is the first oral proteasome inhibitor to enter the clinic. Given the efficacy of bortezomib in combination with cyclophosphamide and dexamethasone,…”
Get full text

Utility and prognostic value of 18F‐FDG positron emission tomography‐computed tomography scans in patients with newly diagnosed multiple myeloma by Aljama, Mohammed A., Sidiqi, M. Hasib, Buadi, Francis K., Lacy, Martha Q., Gertz, Morie A., Dispenzieri, Angela, Dingli, David, Muchtar, Eli, Fonder, Amie L., Hayman, Suzanne R., Hobbs, Miriam A., Gonsalves, Wilson I., Warsame, Rahma M., Kourelis, Taxiarchis, Hwa, Yi Lisa, Kapoor, Prashant, Kyle, Robert A., Leung, Nelson, Go, Ronald S., Rajkumar, S. Vincent, Kumar, Shaji K.

“…Positron emission tomography‐computed tomography (PET‐CT) can identify bony lesions, assess disease burden, and detect extramedullary disease (EMD) in patients…”
Get full text